Ticker HubNasdaq

MRVI

Maravai LifeSciences Holdings, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS

Latest price

$7.47+2.05%

As of Oct 26, 2026, 7:55 PM EDT · Market data by Massive

Market cap

$1.1B

Volume

1.3M

Previous close

$7.32

Day range

$7.32 – $7.60

Listed

Nov 20, 2020

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $7.19Latest interval $7.47

Newsroom

Latest MRVI coverage

BiotechBusinessAug 22, 2024

Why Maravai LifeSciences Could Be a Perfect Acquisition Target for Repligen

Maravai LifeSciences has recently caught the attention of Repligen as a potential acquisition target, marking it as a significant player in the biotech space.

MRVI

Company overview

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 415
Headquarters: SAN DIEGO, CA
CIK: 0001823239

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Nov 20, 2020

Listed

415

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.